Endothelial negative surface charge areas and blood-brain barrier function
- PMID: 4083048
- DOI: 10.1111/j.1748-1716.1985.tb07746.x
Endothelial negative surface charge areas and blood-brain barrier function
Abstract
Recent evidence points to the negative surface charge of the luminal endothelial membrane of brain vessels as one determinant for morphologic blood-brain barrier function. The present study evaluates, in awake rats, how barrier function is affected by the polycation protamine to neutralize the negatively charged groups. High local doses of protamine, as infused intracarotideally, are able to substantially impair barrier capacity against albumin and inulin, which normally do not pass the blood-brain barrier. Evidence is presented that it is the positive charge of protamine that is a major factor underlying the barrier opening. However, when comparing the barrier opening obtained by corresponding concentration of the polycation lysine, it was obvious that another property of protamine contributed. This property was not linked to hyperosmolar, hypertensive or vasodilatory barrier opening, but may be a direct, cytotoxic effect of protamine. It is discussed whether barrier opening through transendothelial vesicular or channel transport occurs only at locations on the cell membrane deprived of negative surface charge areas.
Similar articles
-
Leakage of blood-retinal barrier due to damaging effect of protamine sulfate on the endothelium.Acta Neuropathol. 1988;76(4):427-31. doi: 10.1007/BF00686981. Acta Neuropathol. 1988. PMID: 3176906
-
Altering the blood-brain barrier in the rat by intracarotid infusion of polycations: a comparison between protamine, poly-L-lysine and poly-L-arginine.Acta Physiol Scand. 1993 Sep;149(1):99-104. doi: 10.1111/j.1748-1716.1993.tb09597.x. Acta Physiol Scand. 1993. PMID: 8237428
-
Charge-related alterations of the cerebral endothelium.Lab Invest. 1983 Dec;49(6):662-71. Lab Invest. 1983. PMID: 6656198
-
Experimental models of altering the blood-brain barrier.Prog Brain Res. 1992;91:171-5. doi: 10.1016/s0079-6123(08)62332-8. Prog Brain Res. 1992. PMID: 1410402 Review.
-
The blood-brain barrier in acute and chronic hypertension.Adv Exp Med Biol. 1980;131:211-26. doi: 10.1007/978-1-4684-3752-2_17. Adv Exp Med Biol. 1980. PMID: 7001869 Review. No abstract available.
Cited by
-
Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium.J Clin Invest. 1993 Nov;92(5):2224-9. doi: 10.1172/JCI116825. J Clin Invest. 1993. PMID: 8227337 Free PMC article.
-
From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.Nat Rev Drug Discov. 2016 Apr;15(4):275-92. doi: 10.1038/nrd.2015.21. Epub 2016 Jan 22. Nat Rev Drug Discov. 2016. PMID: 26794270 Review.
-
Xenobiotic pulmonary exposure and systemic cardiovascular response via neurological links.Am J Physiol Heart Circ Physiol. 2015 Nov 15;309(10):H1609-20. doi: 10.1152/ajpheart.00546.2015. Epub 2015 Sep 18. Am J Physiol Heart Circ Physiol. 2015. PMID: 26386111 Free PMC article. Review.
-
CNS drug delivery: opioid peptides and the blood-brain barrier.AAPS J. 2006 Feb 24;8(1):E76-88. doi: 10.1208/aapsj080109. AAPS J. 2006. PMID: 16584136 Free PMC article. Review.
-
Leakage of blood-retinal barrier due to damaging effect of protamine sulfate on the endothelium.Acta Neuropathol. 1988;76(4):427-31. doi: 10.1007/BF00686981. Acta Neuropathol. 1988. PMID: 3176906
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources